Judith L. P.
- Country
- France
- Department
- ONCOLOGIE
Research Overview
- A Phase I/II Study of Pembrolizumab (MK-3475) in children with advanced melanoma or a PD-L1 positive advanced, relapsed or refractory solid tumor or lymphoma (KEYNOTE-051)
- Phase II Evaluation of Pembrolizumab with Chemotherapy in Pediatric and Young Adult Classical Hodgkin Lymphoma with Slow Early Response
- Phase 1B Evaluation of Crizotinib Alone or with Temsirolimus in Pediatric ALK, ROS1, or MET-Positive Malignancies
Data & Insights
Has run more than one trial at 18 of 68 partner sites.
Specializations
Lymphoma Specialization
The investigator demonstrates significant expertise in treating various forms of lymphoma, particularly focusing on classical Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL). Their research encompasses innovative approaches for both pediatric and young adult populations.
- Classical Hodgkin Lymphoma Treatment
- ALK-Positive ALCL Management
- Refractory Lymphoma Therapy
Their work extends to both newly diagnosed cases and relapsed/refractory disease states.
Pediatric Oncology
The investigator specializes in treating complex pediatric malignancies, with particular attention to solid tumors and inflammatory myofibroblastic tumors (IMT). Their expertise includes managing rare pediatric conditions and developing targeted therapeutic approaches.
- Neuroblastoma Treatment
- Rhabdomyosarcoma Therapy
- Pediatric Solid Tumors
Their research addresses various molecular targets including ALK, ROS1, and MET positive malignancies.
Immunotherapy Innovation
The investigator focuses on advancing immunotherapy treatments through novel therapeutic combinations. Their work encompasses various immunotherapy agents including pembrolizumab, nivolumab, and innovative combination approaches.
- Checkpoint Inhibitor Therapy
- Combination Immunotherapy
- Novel Treatment Strategies
Their research explores both monotherapy and combination approaches in resistant disease settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.